放疗与局灶消融后挽救性机器人辅助腹腔镜前列腺切除术的结局比较
本研究比较了126例接受挽救性机器人辅助腹腔镜前列腺切除术的患者,其中94例(74.6%)原发治疗为放疗,32例(25.4%)为局灶消融。结果显示局灶消融组术后1年控尿率更高,但非器官局限性疾病和切缘阳性率更高,5年无生化复发生存率两组相似(59% vs 56%;P=0.761)。
要点
- 局灶消融组术后1年完全控尿率77.3% vs 放疗组39.2%(P=0.002)。
- 局灶消融组非器官局限性疾病71% vs 放疗组50%(P=0.042),切缘阳性率43.8% vs 17%(P=0.004)。
- 5年无生化复发生存率两组相似(59% vs 56%;P=0.761)。
核心结论
- 放疗与挽救性RALP后较差的功能结局相关;局灶治疗与非器官局限性疾病和切缘阳性率较高相关,但短期无生化复发生存率无显著差异。
研究设计与样本
- 研究评估了2008年至2018年间接受挽救性RALP的126例患者,其中94例(74.6%)原发治疗为放疗,32例(25.4%)为局灶消融,比较两组临床、肿瘤学和功能结局,使用Kaplan-Meier曲线和回归模型识别生存估计及其预测因素。
主要发现
- 术前局灶消融组勃起功能保留率高于放疗组(46.9% vs 22.6%;P=0.013)。
- 围手术期特征和并发症率两组无显著差异;术后导尿时间局灶消融组更短(平均10天 vs 16天;P=0.018)。
- 最终病理局灶消融组非器官局限性疾病率71% vs 放疗组50%(P=0.042),切缘阳性率43.8% vs 17%(P=0.004);5年无生化复发生存率相似(59% vs 56%;P=0.761)。
- 术后1年完全控尿率(无尿垫/天)局灶消融组77.3% vs 放疗组39.2%(P=0.002),社交控尿率(0-1尿垫/天)87.5% vs 51.3%(P=0.002)。
- 多变量分析显示原发局灶消融和神经保留是术后控尿的预测因素;术前有勃起功能的患者中,放疗组和局灶消融组分别有13%和27%保留勃起功能(P=0.435),未发现术后勃起功能的预测因素。
关键数值与推荐
- 术前勃起功能保留率:局灶消融组46.9% vs 放疗组22.6%(P=0.013)。
- 术后导尿时间:局灶消融组平均10天 vs 放疗组16天(P=0.018)。
- 非器官局限性疾病率:局灶消融组71% vs 放疗组50%(P=0.042);切缘阳性率:43.8% vs 17%(P=0.004)。
- 5年无生化复发生存率:局灶消融组59% vs 放疗组56%(P=0.761)。
- 术后1年完全控尿率:77.3% vs 39.2%(P=0.002);社交控尿率:87.5% vs 51.3%(P=0.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare salvage robot-assisted laparoscopic prostatectomy (RALP) outcomes in patients who underwent radiation and those who underwent focal ablation as primary therapies. PATIENTS AND METHODS: We evaluated 126 patients who underwent salvage RALPbetween 2008 and 2018. Of these, 94 (74.6%) received radiation and 32 focal ablation (25.4%) as primary therapy. These groups were compared with regard to clinical, oncological and functional outcomes. Kaplan-Meier curves and regression models were used to identify survival estimations and their predictors. RESULTS: Before surgery, more patients were potent in the focal ablation group compared to the radiation group (46.9% vs 22.6%; P = 0.013). Peri-operative characteristics and complication rates were not significantly different between the two groups. Postoperative catheterization duration was shorter in the focal ablation group (mean 10 vs 16 days; P = 0.018). At final pathology, the focal ablation group had higher non-organ-confined disease (71% vs 50%; P = 0.042) and positive surgical margin (PSM) rates (43.8% vs 17%; P = 0.004) as compared to the radiation group; however, 5-year biochemical recurrence (BCR)-free survival rates were similar (59% vs 56%; P = 0.761). Postoperative 1-year full (no pads/day) and social (0-1 pad/day) continence rates were significantly higher in the focal ablation as compared to the radiation group (77.3% vs 39.2%, P = 0.002, and 87.5% vs 51.3%, P = 0.002, respectively). Multivariate analyses showed primary focal ablation and nerve-sparing to be predictors of postoperative continence. Erectile function was preserved in 13% and 27% of preoperatively potent patients in the radiation and focal ablation groups, respectively (P = 0.435). No predictors were identified for postoperative potency. CONCLUSIONS: Radiation was associated with inferior functional outcomes after salvage RALP. Focal therapies were associated with higher non-organ-confined disease and PSMrates, with no significant difference in short-term BCR-free survival.
引用
- Onol FF, Bhat S, Moschovas M, et al. Comparison of outcomes of salvage robot-assisted laparoscopic prostatectomy for post-primary radiation vs focal therapy. BJU Int. 2019. PMID: 31430422. doi:10.1111/bju.14900
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。